Indigenous Rotovac Vaccine Raises Safety Concerns
Highlights:
- Rotovac is linked to a 1.6-fold increase in intussusception risk
- Bharat Biotech refutes study findings, citing thorough safety evaluations
- Emphasis on parental awareness and ongoing vigilance in vaccine programs
Bharat Biotech's Rotovac, an indigenous rotavirus vaccine included in the Indian government's immunisation program, has recently come under scrutiny. A study reported by the Economic Times from the International Journal of Risk and Safety in Medicine has linked the vaccine to an increased risk of intussusception in infants (1✔).
Rotovac and Its Potential Risks
Intussusception is a severe medical condition where a part of the intestine folds into an adjacent section. This can lead to severe complications, including bowel gangrene and potentially death if not treated immediately. It is crucial to understand this risk, especially in the context of widespread vaccination programs.‘Did You Know?
The risk of intussusception in infants may rise by 1.6 times with Rotovac. #medindia #vaccineawareness’
The study, co-authored by Jacob Puliyel, MD of the International Institute of Health Management Research, India, and Brian Hooker of Children's Health Defense, found a 1.6-fold increased risk of intussusception among infants vaccinated with Rotovac. This heightened risk was not detected in initial analyses, raising concerns about the vaccine's safety profile. Puliyel emphasized the importance of parents being aware of this risk since the symptoms of intussusception can resemble those of dysentery.
Bharat Biotech's Safety Assurance
Bharat Biotech reaffirmed the safety of Rotovac, highlighting that it is manufactured from human rotavirus strains, not animal origins. They criticized the recent study's methodology, claiming it deviated from established statistical plans, thereby questioning its validity. The company remains confident in the vaccine's safety and efficacy.While Bharat Biotech stands by its product, the study underscores the need for ongoing vigilance and transparency in vaccination programs. It is essential for healthcare providers and parents to stay informed about potential risks associated with vaccines to make well-informed decisions for their children's health.
The debate over Rotovac's safety highlights the complexities and challenges in vaccine safety monitoring. As research continues, it is vital to balance the benefits of widespread immunisation against potential risks, ensuring the well-being of all infants.
Awareness is the first step toward ensuring our children's health and safety.
Reference:
- Rotavirus vaccine in India faces controversy - (https:www.ncbi.nlm.nih.gov/pmc/articles/PMC3761026/)
Source: Medindia
Cite this Article ⇣⇡
Please use one of the following formats to cite this article in your essay, paper or report:
-
APA
Dr. Pavithra. (2024, June 19). Indigenous Rotovac Vaccine Raises Safety Concerns. Medindia. Retrieved on Jul 04, 2024 from https://www.medindia.net/news/healthwatch/indigenous-rotovac-vaccine-raises-safety-concerns-216091-1.htm.
MLA
Dr. Pavithra. "Indigenous Rotovac Vaccine Raises Safety Concerns". Medindia. Jul 04, 2024. <https://www.medindia.net/news/healthwatch/indigenous-rotovac-vaccine-raises-safety-concerns-216091-1.htm>.
Chicago
Dr. Pavithra. "Indigenous Rotovac Vaccine Raises Safety Concerns". Medindia. https://www.medindia.net/news/healthwatch/indigenous-rotovac-vaccine-raises-safety-concerns-216091-1.htm. (accessed Jul 04, 2024).
Harvard
Dr. Pavithra. 2024. Indigenous Rotovac Vaccine Raises Safety Concerns. Medindia, viewed Jul 04, 2024, https://www.medindia.net/news/healthwatch/indigenous-rotovac-vaccine-raises-safety-concerns-216091-1.htm.